Management of COVID-19 pandemic makes it imperative for global healthcare systems to adopt robust practices for the detection. A prominent and successful method that gathered wide uptake is detection of SARS-CoV-2 nucleic acid in upper respiratory specimens using oropharyngeal swabs (OPS) and nasopharyngeal swabs (NPS). Nasal swab tests have contributed to the risk assessment of transmission and the acceptance of the tests has led to quarantine decisions. The drive for COVID-19 nasal swab tests market stems from this trend.
Get Sample Copy of this Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=7661
A number of sample studies, albeit in small populations, have endorsed that the detection rate of SARS-CoV-2 was higher in nasal swabs than in pharyngeal swabs. In several countries, the tests have been used to reduce the viral load, particularly in paired NPS and OPS. All these have paved way to favorable developments in COVID-19 nasal swab tests market.
Efforts to Increase Sensitivity and Reduce Discomfort of Sample Collection Ongoing
Despite the vast popularity and the adoption, the discomfort and invasiveness of the tests have concerned many, the diagnostic sensitivity of NPS has been found to higher than OPS, given the fact that SARS-CoV-2 load was higher in the former. This continues to enrich the landscape of the COVID-19 nasal swab tests market. Efforts are ongoing to make them more comfortable as well increasing the sensitivity in late-stage disease.
The aspect has led to pressing need to increase the awareness of complications. Adverse reactions are nonetheless very rare. Interestingly but unsurprisingly, researchers are documenting the adverse events in standardized methods, which is boosting COVID-19 nasal swab tests market. Furthermore, the global healthcare system has woken up to the need for creating provision of appropriate diagnostic and therapeutic measures should an adverse reaction occur despite all precautions.
Check Table of Contents of this Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=7661
The COVID-19 nasal swab tests market has benefitted from millions of tests being performed daily around the world. The growing number of individuals who are asymptomatic and have low probability for acute infections further serves to steer the growth of the market.